Anti-inflammatory mechanisms of phenanthroindolizidine alkaloids

Molecular Pharmacology

Volumn 69, Issue 3, 2006, Pages 749-758

  Yang, Cheng Wei ^b   Chen, Wei Liang ^b   Wu, Pei Lin ^b   Tseng, Huan Yi ^b   Lee, Shiow Ju ^a  

^a Division of Biotechnology and Pharmaceutical Research   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID DERIVATIVE; CYCLOOXYGENASE 2; FICUSEPTINE A; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENANTHROINDOLIZIDINE ALKALOID DERIVATIVE; PROTEIN C JUN; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; TYLOPHORINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; DRUG ISOLATION; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; FICUS; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADAPTOR PROTEIN COMPLEX 1; ALKALOIDS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CHROMONES; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; FICUS; INDOLIZINES; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; MORPHOLINES; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHENANTHRENES; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RESPONSE ELEMENTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644845305     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.017764     Document Type: Article

References (41)

1. Abe F, Hirokawa M, Yamauchi T, Honda K, Hayashi N, Ishii M, Imagawa S, and Iwahana M (1998) Further investigation of phenanthroindolizidine alkaloids from Tylophora tanakae. Chem Pharm Bull (Tokyo) 46:767-769.
2. Adcock IM (1997) Transcription factors as activators of gene transcription: AP-1 and NF-kappa B. Monaldi Arch Chest Dis 52:178-186.
3. Aikin R, Maysinger D, and Rosenberg L (2004) Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets. Endocrinology 145:4522-4531.
4. Cerezo A, Martinez AC, Lanzarot D, Fischer S, Franke TF, and Rebollo A (1998) Role of Akt and c-Jun N-terminal kinase 2 in apoptosis induced by interleukin-4 deprivation. Mol Biol Cell 9:3107-3118.
5. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, and Evans RM (2001) PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 7:48-52.
6. Chen KX, Gresh N, and Pullman B (1986) A theoretical study of anthracene and phenanthrene derivatives acting as A-T specific intercalators. Nucleic Acids Res 14:9103-9115.
7. Chu SC, Marks-Konczalik J, Wu HP, Banks TC, and Moss J (1998) Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem Biophys Res Commun 248:871-878.
8. Cross RK and Wilson KT (2003) Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis 9:179-189.
9. Funakoshi-Tago M, Tago K, Sonoda Y, Tominaga S, and Kasahara T (2003) TRAF6 and C-SRC induce synergistic AP-1 activation via PI3-kinase-AKT-JNK pathway. Eur J Biochem 270:1257-1268.
10. Ganguly T and Sainis KB (2001) Inhibition of cellular immune responses by Tylophora indica in experimental models. Phytomedicine 8:348-355.
11. Gao W, Lam W, Zhong S, Kaczmarek C, Baker DC, and Cheng YC (2004) Novel mode of action of tylophorine analogs as antitumor compounds. Cancer Res 64:678-688.
12. Giuliani C, Napolitano G, Bucci I, Montani V, and Monaco F (2001) NF-κB transcription factor: role in the pathogenesis of inflammatory, autoimmune and neoplastic diseases and therapy implications. Clin Ter 152:249-253.
13. Go YM, Boo YC, Park H, Maland MC, Patel R, Pritchard KA Jr, Fujio Y, Walsh K, Darley-Usmar V, and Jo H (2001) Protein kinase B/Akt activates c-Jun NH(2)-terminal kinase by increasing NO production in response to shear stress. J Appl Physiol 91:1574-1581.
14. Gopalakrishnan C, Shankaranarayan D, Kameswaran L, and Natarajan S (1979) Pharmacological investigations of tylophorine, the major alkaloid of Tylophora indica. Indian J Med Res 69:513-520.
15. Gopalakrishnan C, Shankaranarayanan D, Nazimudeen SK, and Kameswaran L (1980) Effect of tylophorine, a major alkaloid of Tylophora indica, on immunopathological and inflammatory reactions. Indian J Med Res 71:940-948.
16. Guha M and Mackman N (2001) LPS induction of gene expression in human monocytes. Cell Signal 13:85-94.
17. Huntley A and Ernst E (2000) Herbal medicines for asthma: a systematic review. Thorax 55:925-929.
18. Komatsu H, Watanabe M, Ohyama M, Enya T, Koyama K, Kanazawa T, Kawahara N, Sugimura T, and Wakabayashi K (2001) Phenanthroindolizidine alkaloids as cytotoxic substances in a danaid butterfly, Ideopsis similis, against human cancer cells. J Med Chem 44:1833-1836.
19. Kosaka T, Miyata A, Ihara H, Hara S, Sugimoto T, Takeda O, Takahashi E, and Tanabe T (1994) Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur J Biochem 221:889-897.
20. 2/M cell cycle arrest mediated by antofine, a phenanthroindolizidine alkaloid isolated from Cynanchum paniculatum. Planta Med 69:21-25.
21. Levresse V, Butterfield L, Zentrich E, and Heasley LE (2000) Akt negatively regulates the cJun N-terminal kinase pathway in PC12 cells. J Neurosci Res 62:799-808.
22. Li J, Chen H, Tang MS, Shi X, Amin S, Desai D, Costa M, and Huang C (2004) PI-3K and Akt are mediators of AP-1 induction by 5-MCDE in mouse epidermal Cl41 cells. J Cell Biol 165:77-86.
23. Liang YC, Tsai SH, Tsai DC, Lin-Shiau SY, and Lin JK (2001) Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages. FEBS Lett 496:12-18.
24. Liou JP, Chang YL, Kuo FM, Chang CW, Tseng HY, Wang CC, Yang YN, Chang JY, Lee SJ, and Hsieh HP (2004) Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents. J Med Chem 47:4247-4257.
25. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, and Murphy WJ (1993) Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA 90:9730-9734.
26. Monick MM and Hunninghake GW (2003) Second messenger pathways in pulmonary host defense. Annu Rev Physiol 65:643-667.
27. Pettit GR, Goswami A, Cragg GM, Schmidt JM, and Zou JC (1984) Antineoplastic agents, 103. The isolation and structure of hypoestestatins 1 and 2 from the East African Hypoestes verticillaris. J Nat Prod 47:913-919.
28. Raina V and Raina S (1980) The responsiveness of leukocyte adenyl cyclase to tylophorine in asthmatic subjects. Biochem Biophys Res Commun 94:1074-1077.
29. Rao KN, Bhattacharya RK, and Venkatachalam SR (1997) Inhibition of thymidylate synthase and cell growth by the phenanthroindolizidine alkaloids pergularinine and tylophorinidine. Chem Biol Interact 106:201-212.
30. Rao KN and Venkatachalam SR (2000) Inhibition of dihydrofolate reductase and cell growth activity by the phenanthroindolizidine alkaloids pergularinine and tylophorinidine: the in vitro cytotoxicity of these plant alkaloids and their potential as antimicrobial and anticancer agents. Toxicol In Vitro 14:53-59.
31. Ricote M, Li AC, Willson TM, Kelly CJ, and Glass CK (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature (Lond) 391:79-82.
32. Ristimaki A (2004) Cyclooxygenase 2: from inflammation to carcinogenesis. Novartis Found Symp 256:215-226, 259-269.
33. Shimoke K, Yamagishi S, Yamada M, Ikeuchi T, and Hatanaka H (1999) Inhibition of phosphatidylinositol 3-kinase activity elevates c-Jun N-terminal kinase activity in apoptosis of cultured cerebellar granule neurons. Brain Res Dev Brain Res 112:245-253.
34. Staerk D, Christensen J, Lemmich E, Duus JO, Olsen CE, and Jaroszewski JW (2000) Cytotoxic activity of some phenanthroindolizidine N-oxide alkaloids from Cynanchum vincetoxicum. J Nat Prod 63:1584-1586.
35. Staerk D, Lykkeberg AK, Christensen J, Budnik BA, Abe F, and Jaroszewski JW (2002) In vitro cytotoxic activity of phenanthroindolizidine alkaloids from Cynanchum vincetoxicum and Tylophora tanakae against drug-sensitive and multidrugresistant cancer cells. J Nat Prod 65:1299-1302.
36. Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G, and Glass CK (2000) 15-Deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci USA 97:4844-4849.
37. Thieringer R, Fenyk-Melody JE, Le Grand CB, Shelton BA, Detmers PA, Somers EP, Carbin L, Moller DE, Wright SD, and Berger J (2000) Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo. J Immunol 164:1046-1054.
38. Trifan OC and Hla T (2003) Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. J Cell Mol Med 7:207-222.
39. Watson A, Eilers A, Lallemand D, Kyriakis J, Rubin LL, and Ham J (1998) Phosphorylation of c-Jun is necessary for apoptosis induced by survival signal withdrawal in cerebellar granule neurons. J Neurosci 18:751-762.
40. Wu P-L, Rao KV, Su C-H, Kuoh C-S, and Wu T-S (2002) Phenanthroindolizidine alkaloids and their cytotoxicity from the leaves of Ficus septica. Heterocycles 57:2401-2408.
41. Yuan CJ, Mandal AK, Zhang Z, and Mukherjee AB (2000) Transcriptional regulation of cyclooxygenase-2 gene expression: novel effects of nonsteroidal antiinflammatory drugs. Cancer Res 60:1084-1091.